Author
Listed:
- Po-Hsun Chuang
(Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou 333, Taiwan
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
- Kai-Fan Tsai
(College of Medicine, Chang Gung University, Taoyuan 333, Taiwan
Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan)
- I-Kuan Wang
(Department of Nephrology, China Medical University Hospital, Taichung 404, Taiwan
College of Medicine, China Medical University, Taichung 406, Taiwan)
- Ya-Ching Huang
(College of Medicine, Chang Gung University, Taoyuan 333, Taiwan
Department of Laboratory Medicine, Chang Gung Memorial Hospital, Linkou 333, Taiwan)
- Lan-Mei Huang
(Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou 333, Taiwan)
- Shou-Hsuan Liu
(Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou 333, Taiwan
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
- Cheng-Hao Weng
(Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou 333, Taiwan
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
- Wen-Hung Huang
(Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou 333, Taiwan
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
- Ching-Wei Hsu
(Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou 333, Taiwan
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
- Wen-Chin Lee
(College of Medicine, Chang Gung University, Taoyuan 333, Taiwan
Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan)
- Tzung-Hai Yen
(Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou 333, Taiwan
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan)
Abstract
Background. This retrospective observational study attempted to examine the prevalence of abnormal blood aluminum levels in dialysis patients, and to explore the association of pathogenic factors, such as demographic, clinical, laboratory as well as the use of phosphate binding drugs, drugs for secondary hyperparathyroidism and erythropoiesis-stimulating drugs with the blood aluminum levels. Methods. The study included 1175 patients (874 hemodialysis and 301 peritoneal dialysis), recruited from Chang Gung Memorial Hospital in November 2020. Patients were stratified into two groups by their blood aluminum levels, as normal (<2 µg/dL, n = 1150) or abnormal (≥2 µg/dL, n = 25). Results. The patients aged 60.4 ± 13.2 years and were dialyzed for 8.6 ± 8.1 years. The average blood aluminum level was 1.0 ± 0.4 µg/dL. Patients with abnormal blood aluminum levels received more sevelamer than patients with normal blood aluminum level ( p = 0.014). Patients with abnormal blood aluminum levels had higher platelet count ( p = 0.001), triglyceride ( p < 0.001) and total iron binding capacity ( p = 0.003) than patients with normal blood aluminum levels. Moreover, the cardiothoracic ratio was higher in patients with abnormal blood aluminum levels than patients with normal blood aluminum levels ( p = 0.003). Conclusions. The prevalence of abnormal blood aluminum levels was low at 2.2%. Nevertheless, the linking of cardiothoracic ratio of more than 0.5 as well as elevated blood platelet count and triglyceride level with blood aluminum levels are interesting, and warranted more researches in this area.
Suggested Citation
Po-Hsun Chuang & Kai-Fan Tsai & I-Kuan Wang & Ya-Ching Huang & Lan-Mei Huang & Shou-Hsuan Liu & Cheng-Hao Weng & Wen-Hung Huang & Ching-Wei Hsu & Wen-Chin Lee & Tzung-Hai Yen, 2022.
"Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis,"
IJERPH, MDPI, vol. 19(7), pages 1-12, March.
Handle:
RePEc:gam:jijerp:v:19:y:2022:i:7:p:3885-:d:778865
Download full text from publisher
References listed on IDEAS
- Shu-Han You & Szu-Chieh Chen & Chin-Hsin Lin & Yen-Chu Chen, 2021.
"Probabilistic Risk Analysis to Assess Dietary Exposure to Aluminum in the Taiwanese Population,"
IJERPH, MDPI, vol. 18(3), pages 1-17, January.
- Pei-Ching Chang & Shao-Yu Tai & Chia-Lin Hsu & Aileen I. Tsai & Jen-Fen Fu & I-Kuan Wang & Cheng-Hao Weng & Tzung-Hai Yen, 2021.
"Torus Mandibularis in Patients Receiving Hemodialysis,"
IJERPH, MDPI, vol. 18(18), pages 1-10, September.
Full references (including those not matched with items on IDEAS)
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:7:p:3885-:d:778865. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.